GenSci148
/ GeneScience
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 15, 2026
GenSci148-101: A Phase I Study of GenSci148 Intravitreal Injection for Neovascular Age-related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion
(clinicaltrials.gov)
- P1 | N=60 | Not yet recruiting | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
New P1 trial • Age-related Macular Degeneration • Diabetic Macular Edema • Macular Degeneration • Ophthalmology • Retinal Disorders • Retinal Vein Occlusion • Wet Age-related Macular Degeneration
1 to 1
Of
1
Go to page
1